No Data
No Data
No Data
No Data
No Data
Is Intco Medical Technology (SZSE:300677) Weighed On By Its Debt Load?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh
Simply Wall StMar 28 21:32 ET
Intco Medical Technology Co., Ltd.'s (SZSE:300677) Largest Shareholders Are Retail Investors With 51% Ownership, Insiders Own 35%
Key Insights Intco Medical Technology's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public The top 25 shareholders own 48% o
Simply Wall StMar 1 17:19 ET
British Healthcare (300677.SZ): 0.69% of shares have been repurchased cumulatively
Gelonghui, March 1, 丨 British Healthcare (300677.SZ) announced that as of February 29, 2024, the company had repurchased 4,504,300 shares of the company's shares through a dedicated stock repurchase securities account, accounting for 0.6866% of the company's total share capital (based on calculation of 656,009,601 shares on February 29, 2024). The highest transaction price was 23.75 yuan/share, and the total transaction amount was RMB 100,015,581.00 (excluding transactions) costs).
Gelonghui FinanceMar 1 02:45 ET
There's Reason For Concern Over Intco Medical Technology Co., Ltd.'s (SZSE:300677) Price
With a price-to-earnings (or "P/E") ratio of 38.7x Intco Medical Technology Co., Ltd. (SZSE:300677) may be sending bearish signals at the moment, given that almost half of all companies in China have
Simply Wall StFeb 3 19:43 ET
British Healthcare (300677.SZ) has repurchased a total of 4,504,300 shares at a cost of 100 million yuan
British Healthcare (300677.SZ) announced that as of January 31, 2024, the company has repurchased 4 of the company's shares...
Zhitong FinanceFeb 1 05:14 ET
British Healthcare (300677.SZ): Intended to participate in Haining Qingling Venture Capital Fund Partnership
Gelonghui, January 25 | Yingke Healthcare (300677.SZ) announced that in order to further optimize the investment structure and enhance investment value, Inke Medical Technology Co., Ltd. plans to sign the “Haining Qingling Venture Capital Fund Partnership (Limited Partnership) Partnership Agreement” with Shanghai Rongxi Venture Capital Management Co., Ltd. (“Shanghai Rongxi”) to participate in investing in Haining Qingling Venture Capital Fund Partnership (limited partnership) (tentative name, subject to industrial and commercial approval, abbreviated as “partnership”, “fund” or “fund”). The total amount of capital pledged by the partnership is no more than 100 million yuan (the currency is human
Gelonghui FinanceJan 25 03:32 ET
No Data
No Data